The objective of the study is to evaluate, in a clinical trial, the efficacy of peri operative administration of long-acting inhaled ß-2 mimetics on the occurrence of postoperative pulmonary complications
Adult (>18 years)
Lung cancer eligible for surgical management by lung resection (non-small cell lung carcinoma = NSCLC) by any route
Naïve to long-term inhaled bronchodilator therapy
High risk of post-operative pulmonary complications (Pre-operative FEV1 < 80%)
Patient refusal
Pregnancy
Emergency surgery
Patient with a physiological status of WHO IV or ASA ≥ IV